Program Council
PhD Rick Doblin
Founder and President of MAPS, pioneer of psychedelic research
Founder and President of MAPS, pioneer of psychedelic research
Rick Doblin
Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four-year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. Learn more about Rick by listening to his Origin Story and watching his TED Talk.
MD, PhD Eric Vermetten
Psychiatrist, Neuroscientist, and expert in trauma and PTSD
Psychiatrist, Neuroscientist, and expert in trauma and PTSD
Eric Vermetten
Prof dr HGJM Eric Vermetten, MD, PhD, is a clinical psychiatrist working with veterans and other uniformed officers as Strategic Advisor (COL) of Research at the Military Mental Health Service with the Dutch Ministry of Defense and ARQ National Psychotrauma Center. He holds an endowed chair in Psychiatry at the Department Psychiatry at Leiden UMC. He also has an Adjunct Professorship at the Department Psychiatry of New York UMC. He is trained in the Netherlands as well as in the USA in psychiatry and neuroscience (Stanford, Yale and Emory University). He has clinical as well as a research positions with a focus on medical/biological as well as psychiatric aspects of complex psychotrauma in military as well as civilian populations. He has published over 200 papers, over 30 book chapters and edited several books on this topic. His research is in the field of stress, trauma, complex PTSD and neuroscience. He is interested in the history of war and has special focus on combining biological-based interventions in psychotraumatology with novel technology and novel drug developments, in particular MDMA, psilocybin, ketamine and medical cannabis. He is PI of a 10 year longitudinal cohort study of prospective research in military operations, PRISMO. Prof Vermetten is an ad hoc reviewer for numerous journals and granting agencies. He has lectured on the topic of PTSD, resilience, military and veterans issues as well as novel approaches to therapy across the globe
PhD Adam Stańczyk
Doctor, Cardiologist, Medical Consultant
Adam Stańczyk
Jestem absolwentem Wydziału Lekarskiego Uniwersytetu Medycznego w Łodzi. Z kardiologią związany jestem od czasu studiów, gdzie początkowo w ramach Indywidualnego Toku Studiów a następnie studiów doktoranckich pracowałem w Klinice Kardiologii I Katedry Kardiologii i Kardiochirurgii UM w Łodzi. W latach 2001/2002 byłem stypendystą programu Sokrates Erasmus na Uniwersytecie w Murcii (Hiszpania).
Moje zainteresowania poza kardiologią ogólną koncentrowały się na diagnostyce i leczeniu chorych z omdleniami odruchowymi. Efektem tych lat była obroniona z wyróżnieniem w 2008r praca doktorska "Zmiany neurohormonalne podczas testu pochyleniowego u chorych z omdleniami wazowagalnymi".
W okresie od września 2008r. do lipca 2020r związany byłem z Kliniką Kardiologii i Chorób Wewnętrznych Wojskowego Instytutu Medycznego w Warszawie. Od sierpnia 2020 pracuję w Oddziale Chorób Wewnętrznych USKnr1 im. Norberta Barlickiego w Łodzi, a dodatkowo od października 2020r jestem adiunktem w Zakładzie Farmakologii Klinicznej Uniwersytetu Medycznego w Łodzi.
W 2010r. uzyskałem tytuł specjalisty chorób wewnętrznych, w 2013 specjalisty z hipertensjologii, a w roku 2020 z kardiologii. Dodatkowo w 2013r. ukończyłem studia podyplomowe "Zarządzanie Innowacją w Sektorze Zdrowia" na Akademii im. Leona Koźmińskiego w Warszawie.
PhD Adam Hamed
Neuropsychopharmacologist, Pharmacist, Neurobiologist, Medical Consultant
Neuropsychopharmacologist, pharmacist, and neurobiologist
Adam Hamed
Neuropsychopharmacologist, pharmacist, and neurobiologist, currently a research fellow at the Spatial Memory Laboratory of the Nencki Institute of Experimental Biology, Polish Academy of Sciences. His main areas of interest are individual differences in the activation of the reward system, as controlled by the emission of ultrasonic vocalizations in animals, and the search for the biological and neurochemical foundations of this phenomenon. His research focuses on creating maps (patterns) of reward system activation in various behavioral models related to social interactions, drug addiction, and appetitive contextual response.
Aleksandra Maciejewicz
Lawyer, Patent Attorney, Psychologist in Training, Legal Consultant
Lawyer, Patent Attorney, Psychologist in Training, Legal Consultant
Aleksandra Maciejewicz
Co-founder of LAWMORE, a law firm supporting startups for over a decade. She also founded ONDARE legal/business hub, a company specializing mainly in providing legal services to startups focused on psychedelic substances.
As a lecturer, mentor, and author of the prawodlanaukowca.pl blog, she actively promotes legal knowledge. She works actively to change the legal approach to psychedelic substances. Professionally, she specializes in new technologies law, especially in health tech and computer sciences.
PhD Piotr Marcinowicz
Psychiatrist, Psychiatry Consultant
Psychiatrist, Psychiatry Consultant
Piotr Marcinowicz
In 2021, he founded the Ketamineclinic Psychiatry and Psychotherapy Center to provide comprehensive care to patients with all psychiatric disorders, especially treatment-resistant patients.
He is a psychiatrist who completed his specialization at the Tworkowski Hospital and studied at the Wrocław Medical University. As the first psychiatrist in Poland, he introduced private intravenous ketamine treatment for treatment-resistant depression.
He is a member of the American Society of Ketamine Physicians (askp.org), a doctoral student, and a lecturer at the Medical University of Warsaw. He also conducts his own scientific research.
He is the author of publications on depression, bipolar affective disorder, psychiatric disorders accompanying viral infections, peripartum psychiatric disorders, schizophrenia, and addictions.
As a psychiatrist, he gains multidirectional experience in professional and research work. He is guided by honesty, acceptance, and humility in his work. He loves challenges, and continuous education helps him develop his passion.
He focuses on a partnership model of cooperation in treating his patients. He is not afraid to doubt or verify hypotheses. His work is subject to regular supervision.
He regularly educates himself at foreign psychiatric conferences.
Jakub Schimmelpfennig
Neuropsychologist, Researcher
Psychologist, PhD student in psychology
Jakub Schimmelpfennig
Psychologist, PhD student in the interdisciplinary doctoral school at SWPS University in Warsaw, founder of the Psychedelics & Consciousness Research Group (PCRG). He deals with the use of modern technology and breathing practices to induce altered states of consciousness and the area of psychedelics, with particular emphasis on endogenous DMT.